PulteGroup, Inc. (NYSE: PHM) — The Best Builder in the Group, Re-Rated to Its Richest Multiple Ever at the Top of the Cycle

Independent equity research. Report date: 2026-06-27. As-of price: $137.61 (close 2026-06-26).

⚡ Claude’s Take

This block is the author’s own subjective opinion and general information, not investment advice. The analytical body of this article (sections 1–15 below) deliberately carries no recommendation and no price target; that discipline is intact everywhere except in this clearly-fenced block.

Verdict: HOLD / AVOID-here / accumulate-on-weakness toward book (~$100–115, ~1.5–1.7x the ~$67 book). Not a short. Medium conviction. Fair-value zone ~$105–130 (roughly 1.6–1.9x book, ~10–12x mid-cycle EPS of ~$11–12). The single tag: “the best house on the street — bought at the top of the street, at the top of the cycle.”

PulteGroup is, on the numbers, the highest-quality scale homebuilder in America — and the market has correctly figured that out. It earns the best returns in the cohort (FY25 ROE ~24%, ROIC ~15% in a down year, both comfortably above cost of capital, versus Lennar’s 6.8% ROIC below it), the highest gross margin (26.3% home-sale GM vs LEN’s 17.7%), the highest ASP (~$566k), the best-designed comp plan (paid on ROIC, relative ROE, operating margin and relative TSR — no volume-empire metric), and it carries a genuine fortress balance sheet (net debt-to-capital effectively zero). It is the disciplined-returns operator the others aspire to be, with a uniquely valuable move-up + Del Webb active-adult mix (~60% of the business) that lets it lean into the affluent, less rate-sensitive top leg of a “K-shaped” housing market while peers fight the margin war at the entry level. None of that is in dispute.

The problem is the price and the cycle clock, which point the same direction. PHM trades at its richest valuation in its own recorded history — the stock’s composite own-history valuation percentile sits at the 90th, with price-to-sales at the 97th and P/E at the 92nd — even as the cyclical earnings cycle visibly rolls over: home-sale gross margin has fallen 28.9% → 26.3% → 24.4% (Q1-26), EPS peaked at ~$14.69 (FY24, itself flattered by a ~$334M insurance-reserve release) and is now ~$10.34 TTM and heading lower, and orders/backlog are shrinking. The seductive 13x trailing P/E is the classic cyclical trap: a low multiple on near-peak earnings is not cheap. On the cleaner P/B lens, ~2.06x is the top of PHM’s normal (ex-2021-bubble) range, and the stock sits just 6% below its all-time high after nearly quadrupling off the 2022 low — the exact mirror image of Lennar, which trades near book 43% off its peak. This is a quality-compounder-at-a-rich-price riding a rate-cut + housing-bill momentum bid (FactorsToday: dominant Home-Construction beta 2.0, InterestRate loading −0.84, near-ATH momentum), not a contrarian value setup. I would happily own the best operator in the group — I would not pay an all-time-high multiple for it with earnings declining and the whole thesis levered to a mortgage-rate cut the market has already started to celebrate.

Conviction: medium. The one piece of evidence that flips me bullish: the 30-year mortgage falling toward ~5.5% and reigniting first-time/entry demand while PHM’s gross margin stabilizes above ~25% and orders re-accelerate — proving the earnings roll-over was a shallow mid-cycle dip, not a peak. The one piece that flips me bearish (toward an outright avoid/trim): home-sale gross margin breaking below ~23% with orders still declining and the rate-cut bid fading — a setup that historically returns this stock toward book value (~$100 or below), which is a ~25–30% drawdown from here.

📈 Stock Price Action — Five-Year Event Map

Factual price history, not a recommendation. Price moves are FACT; attributed causes are INTERPRETATION. No price targets, no support/resistance levels.

Over the trailing ~60 months PulteGroup ran a powerful cyclical advance and now sits at the very top of it. Split/dividend-adjusted, the stock bottomed at a $34.99 rate-shock low (17-Jun-2022), then roughly quadrupled to an all-time high of $146.95 (18-Oct-2024), consolidated through 2025 (52-week range ~$104.63–141.96), and trades at $137.61 (26-Jun-2026) — only ~−6.4% off the all-time high, near the upper end of its 52-week range, and up ~+33% over the past year. At $137.61 it trades at ~2.06x its ~$66.82 book value and ~13.3x trailing EPS — both near the high end of its own history. This is the inverse of Lennar’s chart (near book, 43% off its peak): PHM is the cohort’s price-action winner, fully re-rated.

Cycle narrative. (1–2) The 2021 boom and 2022 crash were a rate-driven multiple inversion — the violent leg gutted the multiple even as earnings peaked, dropping P/B to ~1.5x. (3–4) The 2023–24 advance more than doubled the stock to an October-2024 all-time high on the buydown machine, the Fed-pivot trade, and record FY24 earnings, with relentless buyback shrinking the float ~26% over five years. (5) The late-2024-to-mid-2025 drawdown reset the multiple on “higher-for-longer” as margins began to compress. (6) A 2025 rate-cut-hope rally and the “PHM-is-the-best-operator” narrative carried it back near $142. (7) The Q1-2026 print (EPS −34% YoY, GM 24.4%) reminded the market the earnings cycle is rolling over. (8) The late-June bounce is a sector-wide relief rally on the bipartisan housing bill and a KB Home beat — the same macro/policy bid lifting the entire group, not a PHM-specific catalyst. The stock is near its highs because it is the best operator; the question this memo joins is whether the multiple has run ahead of a declining earnings cycle.

1. Executive Summary

PulteGroup is the third-largest US homebuilder by closings (29,572 homes in FY2025) but arguably the highest-quality and highest-return of the scale builders, generating $17.3B of revenue, $2.22B of net income, and $11.12 diluted EPS in FY2025. Headquartered in Atlanta and operating in 47 markets across 26 states under six brands — Pulte, Centex, Del Webb, DiVosta, John Wieland, and American West — its defining structural feature is a deliberately diversified buyer mix: ~38% first-time (Centex), ~40% move-up (Pulte/DiVosta), and ~22% active-adult (Del Webb). That mix, skewed ~60% toward affluent move-up and 55+ active-adult buyers, drives the group’s highest average selling price (~$566,000) and lets PHM lean into the strongest, least rate-sensitive segments of demand while peers concentrate at the rate-whipped entry level. A captive mortgage/title arm (Pulte Financial Services) attaches to ~64% of closings and adds a high-return earnings layer (~5% of pretax income).

The investment debate is not about business quality — PHM wins that — but about price at this point in the cycle. PHM earns the best economics in the cohort: FY2025 ROE ~24% and ROIC ~15% (both above cost of capital, in a down year) versus Lennar’s 8.6%/6.8% (below it); home-sale gross margin of 26.3% versus Lennar’s 17.7%; and a comp plan that pays explicitly on ROIC, relative ROE, operating margin, and relative TSR with no volume/revenue empire metric. Capital allocation is genuinely excellent — ~26% share-count reduction over five years via consistent buyback, a +18% dividend hike, a Feb-2026 debt refinancing into lower coupons, and a net-cash balance sheet — and management is visibly returns-disciplined, cutting starts below orders and shifting back toward a higher-margin 60% build-to-order mix.

But three facts sit in tension with the ~2.06x book / 13.3x earnings valuation. First, earnings are rolling over from a cyclical peak: home-sale gross margin has compressed 28.9% → 26.3% → 24.4% (Q1-26), EPS peaked at $14.69 in FY2024 (itself flattered by a ~$334M one-time insurance-reserve release), TTM EPS is now ~$10.34 and falling, and FY25 closings (−5%), orders (−4%), and backlog (−19%) all declined. Second, the valuation is the richest in PHM’s own recorded history — own-history valuation percentiles: composite 90th, price-to-sales 97th, P/E 92nd, P/B 82nd — a profile that on a cyclical screams “peak multiple on peak-ish earnings,” the textbook cyclical trap (low P/E is deceptive because the E is near a top). Third, the whole complex is levered to a mortgage-rate cut (FactorsToday InterestRate loading −0.84) that the market has already begun to price (the late-June +9% bounce on the housing bill and rate-cut hopes). The stock sits ~6% below its all-time high after nearly quadrupling off the 2022 low — the opposite of a washed-out cyclical. The body that follows discusses valuation only as embedded expectations and scenarios; there is no recommendation and no price target outside Claude’s Take above.

2. Business Overview

What PulteGroup does. PHM acquires and develops residential land and builds and sells single-family detached homes, townhomes, condominiums and duplexes across the United States. Founded in 1950, it is the #3 US builder by closings behind D.R. Horton and Lennar, but it is structured deliberately differently from both: rather than chase maximum entry-level volume, PHM runs a multi-brand, multi-buyer-group portfolio explicitly engineered to spread demand risk across the housing cycle.

The brand/buyer-group architecture (the single most important structural fact about PHM). In FY2025, net new orders and closings split roughly:

• First-time (~38%) — the Centex brand, the most affordable, most rate-sensitive cohort. PHM keeps a deliberate presence here but is under-weight it relative to D.R. Horton.
• Move-up (~40%) — the flagship Pulte and DiVosta brands; higher ASP, more option/upgrade spend, less rate-sensitive.
• Active-adult / 55+ (~22%) — Del Webb, the dominant national active-adult franchise; the most affluent, most cash-rich, least rate-sensitive, and arguably the most defensible part of the entire company.

The economic consequence is large: PHM’s buyers spend over $100,000 per home on options and lot premiums on average (per Q1-26 commentary), and the blended ASP of ~$566,000 is the highest among the scale builders (versus Lennar’s ~$391,000 and D.R. Horton’s ~$380–400k). PHM is a premium, mix-advantaged builder, not a volume-maximizer.

Segments (FY2025, revenue / pretax income).

(FACT — FY2025 10-K, filed 2026-02-04.)

Homebuilding is ~98% of revenue and pretax income. FY2025 closings of 29,572 (−5% YoY) at ~$566k ASP (+2%) produced ~$16.9B of home-sale revenue. New orders were 27,914 units (−4%) / $15.5B (−6%), the cancellation rate ran ~15%, average active communities grew ~5% to 993, and year-end backlog was 8,495 units / $5.27B (−16%/−19%) — only a few months of forward visibility, the recurring reminder that homebuilding revenue is non-recurring: every home is a one-off sale with no switching cost.

Financial Services (Pulte Mortgage, title, insurance agency) is the high-return attach: by originating mortgages for ~64% of its own buyers (with ~21% paying cash — a tell of the affluent mix), PHM captures a low-capital earnings layer that earned $158M pretax. It is cyclically tied to the home sale and, critically, is the vehicle through which PHM offers the mortgage-rate buydowns that are the industry’s affordability tool.

Geography. PHM operates in 47 markets across 26 states organized into six geographic segments, with meaningful exposure to Florida, Texas, Arizona, the Carolinas, and the Mountain West. In FY2025, Texas was the conspicuous weak spot (revenue −22%, closings −20%, pretax −53%) on oversupply and affordability, while Florida re-accelerated (Q1-26 orders +18% statewide) — illustrating both the diversification benefit and the regional dispersion of the current cycle.

Revenue quality. ~98% of revenue is the cyclical, exogenous-demand-driven home sale; the only quasi-recurring, high-return slice is the captive mortgage attach, which itself rides home-sale volume. This is a well-run cyclical industrial with a premium mix — not a compounder with embedded annuity revenue.

Verdict: A premium, returns-disciplined, multi-brand homebuilder whose deliberate move-up/active-adult tilt and highest-in-class ASP give it the best demand mix and economics in the scale cohort — but which remains, at root, a producer of one-off, commodity, cyclically-priced units with no recurring revenue and no demand-side stickiness.

3. Industry Dynamics

Structure. US homebuilding is a fragmented-but-consolidating, commoditized, exogenously-demand-driven cyclical. The top-10 public builders now account for roughly 45% of national closings (up from the low-20s a decade ago), and public builders purchase ~two-thirds of finished lots — a genuine, ongoing consolidation that has structurally improved the industry versus its pre-2008 self. But the product is undifferentiated, the inputs (land ~20%, materials ~40%, labor ~35%, commissions ~5% of cost) are commoditized flow-through, and no large builder enjoys a materially advantaged cost structure versus any other large builder. Through-cycle sector ROIC historically runs ~10–12% — roughly cost of capital — the signature of a structurally average industry.

Demand is frozen, not collapsed — and bifurcated. The defining feature of the 2024–26 environment is a transaction-volume depression rather than a price crash. With ~80% of existing mortgage-holders locked below current rates, the resale market is paralyzed (existing-home sales near multi-decade lows), which channels what demand exists toward new construction — the industry’s one genuine structural positive, because builders can manufacture affordability via rate buydowns where existing-home sellers cannot. But the same ~6.4–6.5% 30-year mortgage that freezes sellers crushes entry-level affordability. The result is the “K-shaped” housing market PHM management describes explicitly: move-up and active-adult (affluent, cash-rich) demand is resilient, while first-time buyers “continue to struggle with stretched affordability and fear of job loss.” PHM’s mix is the single best corporate positioning for this bifurcation — it is over-weight exactly the leg that is holding up.

The capital cycle (Marathon lens). Homebuilding entered this downturn with fortress balance sheets and land-light flexibility — a double-edged structural fact. Capital is not being destroyed (no 2008-style distressed-builder wipeout), so the cycle is being managed shallow, but that also means no washed-out competitors to take share from, muting the survivor-mean-reversion upside that powered prior recoveries. PHM’s increasing reliance on land options (walking away from deposits when projects don’t pencil — $48.4M of option/pre-acquisition write-offs in FY25, up from $18.3M) is the capital cycle in microcosm: builders using optionality to not over-commit, which dampens both downside and the violence of any recovery. (PHM is, fittingly, a textbook Marathon capital-cycle case study — US housing 2002–06 — the lesson being precisely that capital floods homebuilding at the top.)

Regulation and policy. The sector is locally regulated (zoning, entitlement, impact fees) and federally exposed via GSE/FHA mortgage credit, on which the entry-level core depends. The notable June-2026 development: the “21st Century ROAD to Housing Act” cleared Congress with bipartisan margins, restricting large institutional investors from owning 350+ single-family homes, easing manufactured-housing rules, and adding supply-side measures. It drove a sector-wide rally on 24-Jun-2026 (homebuilders’ “best day in a year”). The near-term demand impact is, in builders’ own assessment, modest — affordability is gated by the mortgage rate, not by this bill — so treat the price pop as sentiment/momentum, not a fundamental re-rating. (FACT on passage; INTERPRETATION on de-minimis near-term effect.)

Emerging cost headwinds. Two new pressures bear watching: tariffs on imported building materials (NAHB estimates +~$9,200–10,900 per home) and immigration/labor enforcement disrupting the heavily-immigrant construction trades — both of which raise costs into an environment where builders cannot easily pass price through.

Verdict: A structurally average-to-mediocre industry — commodity product, zero demand captivity, exogenous rate-gated demand, mean-reverting returns — improved at the margin by consolidation, the rate-lock dynamic favoring new construction, and a real multi-million-unit housing deficit. Not a structurally attractive industry; a cyclical one that rewards the best-positioned operators and occasionally offers cyclical mispricings. PHM’s mix makes it the best-positioned operator within it.

4. Competitive Position

The moat, named precisely. In Greenwald’s taxonomy, PHM has a real but narrow supply-side / economies-of-scale cost advantage plus a genuine mix/brand edge in two niches — and essentially no demand-side captivity in the commodity core. The scale advantage (national purchasing leverage, local land access and entitlement know-how, G&A leverage, lower cost of capital than private builders, captive-mortgage buydown capability) is regional, not national, and is shared with D.R. Horton, Lennar, and NVR — it is table-stakes for a scale builder, not a proprietary edge. There are zero customer switching costs in the core: a buyer chooses on price, location, and product, not loyalty.

Where PHM is genuinely differentiated: the Del Webb active-adult franchise and the move-up mix. This is the closest thing to a durable advantage in the company. Del Webb is the dominant national brand in 55+ active-adult communities — a segment with structural tailwinds (aging demographics), the most affluent and cash-rich buyers (lowest rate sensitivity), and a brand that genuinely carries weight with that cohort (a rare instance of homebuyer brand preference). Combined with the move-up Pulte/DiVosta brands, ~60% of PHM’s business sits in segments where it competes less on price and more on community, amenity, and location — which is why PHM sustains a 26%+ gross margin and ~$566k ASP while Lennar runs 17.7% and ~$391k. This mix advantage is hard to replicate quickly (Del Webb’s land positions and brand were built over decades).

The returns prove the quality is real — and the best in the cohort. A durable advantage should show up as persistently superior through-cycle returns, and PHM’s do. ROIC has run 15.3% → 19.7% → 23.8% → 20.7% → 21.8% → 15.2% (FY20–25), never below ~15% even at the FY25 trough — i.e., above cost of capital through the entire cycle, in sharp contrast to Lennar’s FY25 ROIC of 6.8% (below WACC). ROE has normalized from ~50%+ (FY20–22, on a tiny equity base) down to ~24% (FY25) purely because retained earnings have compounded book value 5x (BVPS ~$12 → ~$67); the decline in ROE is healthy de-levering of returns, not deterioration. On every operating-quality metric — gross margin, ASP, ROIC, ROE, returns-discipline of capital allocation — PHM is the strongest of the scale builders.

Land strategy — a deliberate middle path, not maximal land-light. PHM controls ~234,632 lots: 43% owned (101,104) / 57% optioned (133,528), with ~7.9 years’ total supply and ~3.4 years owned. This is meaningfully less land-light than Lennar (~98% optioned, post-Millrose) or NVR (~100% optioned), and more land-light than the land-heavy builders of the pre-2008 era. The trade-off is deliberate and well-judged: by owning ~3–3.5 years of finished/near-finished lots, PHM captures owned-land margin (part of why its gross margin leads the group) and retains the ability to “accelerate as buyer demand improves” (management’s words), while pushing the longer-dated land pipeline into options to limit impairment risk and capital tied up. It bears more cyclical land risk than LEN/NVR (hence the FY25 $77.4M of land impairments and $48.4M of option write-offs) but is compensated in margin. This is a defensible strategic choice, not a weakness — but it does mean PHM is not the capital-light ROIC machine NVR is; its superior returns come from mix and margin, not from NVR-style capital minimization.

Head-to-head.

• vs. NVR (the gold standard): NVR earns ~30%+ ROE on a near-100% optioned, capital-minimized model and trades at ~5.5x book; PHM earns ~24% ROE via mix/margin and trades ~2.06x book. NVR is more capital-efficient; PHM has the better demand mix and higher absolute margin. Different routes to high returns.
• vs. D.R. Horton (#1 by volume): DHI is the entry-level volume leader (~21.5% home-sale GM, ~10.8% ROIC, ~1.9x book); PHM earns higher margin and ROIC on a more affluent mix at a slightly richer multiple. PHM is the higher-quality, DHI the higher-volume.
• vs. Lennar (#2): not close on returns — PHM’s 26.3% GM / 15% ROIC vs LEN’s 17.7% / 6.8%. LEN is cheaper on book (~1.07x vs ~2.06x) precisely because its current returns are the worst in the group. PHM is the quality; LEN is the deep-cyclical value bet.

Verdict: The highest-quality operator in a commodity industry — a narrow scale cost advantage shared with peers, plus a genuinely differentiated Del Webb/move-up mix that produces the best margins and returns in the cohort. The advantage is real and shows up in financial outcomes (sustained above-WACC ROIC, group-leading margin). It is not, however, a wide moat: strip away the mix advantage and PHM would be an average commodity builder, and the mix advantage itself is a cyclical-demand positioning, not a structural toll on a captive customer base.

5. Growth History and Forward Opportunities

History — a powerful multi-year advance now flattening at the top. Revenue grew $11.0B (FY20) → $13.7B → $16.0B → $16.1B → $17.9B (FY24 peak) → $17.3B (FY25, −3.5%). The engine through 2021–24 was the post-COVID demand boom plus margin expansion (home-sale GM peaked ~30% in FY22). Net income roughly doubled $1.41B (FY20) → $3.08B (FY24 peak) and EPS more than doubled $5.24 → $14.82 — turbocharged on a per-share basis by the ~26% reduction in share count. FY2025 is the first down year of the cycle: revenue, closings (−5%), orders (−4%), backlog (−19%), and net income (−28%) all declined.

The current pattern — controlled deceleration, not collapse. Unlike Lennar (which is buying volume with margin), PHM is defending margin and returns at the expense of volume. Closings fell 5% and orders 4%, but PHM grew community count (+5% FY25, +9% in Q1-26) and held ASP up (+2%), and is deliberately cutting starts below orders (Q1-26: ~6,500 starts vs ~8,000 orders) to clear spec inventory and “sell from a position of strength.” Management is also shifting the mix back toward 60% build-to-order / 40% spec (from ~40/60), which structurally supports margin and reduces inventory risk. This is the behavior of a disciplined, returns-first operator — but it also means the growth algorithm from here is community-count-driven and modest, not a return to the 2021–24 surge.

Forward levers, ranked by conviction.

1. Del Webb / active-adult demographic tailwind (highest conviction, most durable). The 55+ cohort is the fastest-growing, most affluent, least rate-sensitive buyer group; Del Webb’s brand and land positions are the company’s best long-duration asset. This lever is real over a decade and relatively cycle-agnostic.
2. Consolidation / share gain. Scaled builders take share from the retreating private long tail every cycle; PHM’s balance-sheet strength lets it keep building and buying land when sub-scale builders retrench. Cycle-agnostic but muted this cycle (no distressed competitors).
3. Community-count growth. The proximate order-growth driver (+9% community count in Q1-26); modest, steady, self-funded.
4. Rate relief → entry-level reacceleration. The largest cyclical upside: a mortgage-rate decline toward ~5.5% would reignite the rate-sensitive Centex/first-time leg and reduce incentive spend — but this is hostage to the macro, not a controllable lever, and is the same option every builder holds.
5. Land “acceleration.” Management explicitly frames its ~35,000 owned-and-finished lots as dry powder to “accelerate as buyer demand improves” — optionality, not a committed growth plan.

M&A. PHM is not an aggressive acquirer; recent growth is organic plus small land/operational deals. This is a positive on capital discipline (it avoids the diworsification risk that plagues serial acquirers) but means inorganic growth is not a meaningful lever.

Verdict: Medium-quality growth, defensively managed. The historical advance was real and high-return, but the company is now in controlled deceleration, prioritizing margin and ROIC over volume — the right choice for shareholders, but one that caps near-term growth at modest, community-count-driven rates. The durable Del Webb demographic tailwind is the best long-term growth asset; the biggest near-term swing factor (entry-level reacceleration) is a rate bet, not an execution lever.

6. Financial Quality

Margins — group-leading, but compressing from a peak. PHM’s reported home-sale gross margin ran ~30% (FY22) → 29.4% (FY23) → 28.9% (FY24) → 26.3% (FY25) → 24.4% (Q1-26), declining each quarter through FY25 (27.5% → 24.7%). This is a real ~460 bps compression off the peak, driven by mortgage-rate buydowns (incentives reached 10.9% of gross sales price in Q1-26 — notably below Lennar’s 13.8%, a direct consequence of the affluent mix needing less subsidy) and higher land/development costs, partly offset by lower construction costs and the build-to-order shift. Even compressed, 26.3% is ~860 bps above Lennar’s 17.7% — the mix and owned-land advantage in one number. Operating margin fell more sharply (21.7% → 17.2% FY24→FY25), but that overstates the operating deterioration because of a one-time SG&A swing discussed below.

Quality-of-earnings — the single most important normalization in this report. PHM’s SG&A carries insurance/self-insurance reserve adjustments (construction-defect IBNR releases) that swing materially year to year: a credit of $333.9M in FY2024, versus only $42.3M in FY2025 and $130.8M in FY2023. The FY2024 release flattered that year’s pretax income by ~$334M (~$1.2–1.3/share) — so FY2024’s “peak” EPS of $14.69 was inflated, and the headline −28% net-income decline FY24→FY25 substantially overstates the underlying operating deterioration. Conversely, FY2025 absorbed offsetting one-time charges: a $28.6M goodwill impairment + $49.6M PP&E impairment (exit of a manufacturing/component operation), $77.4M of land impairments, and $48.4M of option write-offs (Other income swung to −$91.5M from +$61.8M). Normalizing both years, “core” run-rate EPS sits between the reported FY24 and FY25 figures — call it ~$12 of mid-cycle earnings power — and the true peak-to-current operating decline is closer to ~12–15% than the optical 28%. This cuts both ways for the thesis: the business is less deteriorated than the headline (bullish for quality), but it also means the FY24 “$14.69 peak” is not a clean benchmark and current earnings are still above a normalized ~$12 (so not as “trough” as the bulls of a rate-cut rebound assume).

Earnings and returns.

(Sources: FY20–25 10-Ks; aggregated financial data. Home-sale GM per 10-K MD&A; ROE/ROIC on year-end equity. FY24 EPS flattered by ~$334M insurance-reserve release — see QoE.)

The arc is unmistakable: a cyclical peaking in FY2024 and rolling over. ROE’s compression from 50%+ to 24% is mostly the healthy build-up of book; ROIC’s dip to 15.2% is the genuine cyclical margin compression — but 15.2% is still above cost of capital, which is the entire reason PHM deserves (and gets) a premium multiple over LEN.

Balance sheet — fortress. Total debt is just ~$2.3B ($1.6B senior notes + leases) against ~$2.0B cash + $0.6B short-term investments and ~$13.0B equity — net debt of ~$0.18B, or net debt-to-capital of effectively zero (management: “net debt to capital ratio of effectively zero”). Inventory is ~$12.9B (land + homes under construction — PHM owns more land than the land-light peers). Goodwill is negligible (~$40M), so book ≈ tangible book (~$66–67/share). In February 2026 PHM refinanced into lower coupons ($800M of new notes at 4.25%/4.90% to repay/redeem ~$589M of nearer maturities) and upsized/extended its revolver to $1.75B through 2031. A solvency event is essentially off the table short of a 2008-scale depression — in which PHM would be a survivor and share-taker. The balance sheet makes the downside a valuation/return question, not a solvency one.

Cash flow — genuine and well-covered. FY2025 operating cash flow was $1.87B (~84% of net income), against minimal capex (homebuilder capex is embedded in inventory/COGS, not PP&E), so free cash flow was ~$1.87B (~$9.45/share). This comfortably covered the $177M dividend and funded ~$1.2B of buyback. Unlike Lennar’s Millrose-distorted FY25 cash flow (which collapsed to $217M on the transition), PHM’s cash generation is clean and representative — though it does fluctuate with land investment (FY24 OCF was lower at $1.68B on $787M of inventory build; FY22 was just $668M during the land-buying boom). Through the cycle, FCF roughly tracks net income, with land investment the swing factor.

Verdict: The best financial quality in the cohort — economics that genuinely improve with scale/mix, above-WACC ROIC through the entire cycle, group-leading margin, clean cash generation, and a fortress balance sheet. The two cautions: (1) earnings are compressing from a cyclical peak, and (2) the FY24 “peak” was inflated by a one-time reserve release, so current earnings are nearer a normalized ~$12 than a washed-out trough. The quality is real; the question the valuation poses is whether you are buying it at the right point in the cycle.

7. Capital Allocation

Verdict up front: excellent — among the best in the coverage universe. This is PHM’s strongest non-operating attribute and a genuine differentiator.

Buybacks — the primary, consistently-executed return lever. PHM has reduced its share count from 268.5M (FY20) to ~192.7M (FY25 year-end) — roughly −26% in five years — via steady, large repurchases ($1.2B in FY25; ~$0.9–1.2B annually through the period). The board authorized +$1.5B in Jan-2025 and another +$1.5B in Apr-2026, with ~$675M remaining at Q1-26 after a further $308M repurchased that quarter. On a per-share basis this is the engine that turned a doubling of net income (FY20→FY24) into a near-tripling of EPS. The one critique — the same one that applies to every builder — is that buyback is pro-cyclical: PHM is repurchasing at ~2.06x book near an all-time-high stock price, which is far less accretive than buying at the ~1.5x book / $35 lows of 2022. Repurchasing at a return-peak valuation is fine (FCF-funded, EPS-accretive, no balance-sheet strain) but not the contrarian masterstroke that buying the 2022 lows would have been.

Dividend. Raised steadily from $0.48 (FY20) to $0.92 (FY25), then hiked +18% to $0.26/quarter ($1.04 annualized) effective Jan-2026. The yield is low (~0.73%) and the payout ratio minimal (~8%) — deliberately so; PHM (correctly) treats buyback, not dividend, as the primary return vehicle for a cyclical.

Balance-sheet management. Exemplary: net-cash position maintained through the cycle, opportunistic Feb-2026 refinancing into lower coupons and a longer maturity profile, and a disciplined land strategy (43% owned / 57% optioned, increasing optionality, walking away from $48.4M of deposits when projects don’t pencil). Management runs the company for return on invested capital, not size — the defining capital-allocation virtue for a cyclical.

Compensation design — a genuine positive, among the best designed in the sector. The annual bonus is tied to adjusted pre-tax income and operating margin; a separate pre-tax-profit-participation plan benchmarks pre-tax income versus peers; and the three-year LTI PSUs are tied to relative TSR, ROIC, and operating margin, with relative ROE also used. CEO pay is ~94% variable, ~59% long-term. There is no standalone volume/revenue/closings (“empire-building”) metric — the framework’s standard complaint about cyclicals paying for growth-at-any-cost does not apply here; PHM’s plan explicitly rewards capital efficiency and margin. That the FY25 LTI paid out near maximum (relative TSR 194.5%, ROIC 200%, operating margin 200%) reflects genuine multi-year outperformance, and CEO total comp fell with results (~$18.4M FY24 → ~$15.4M FY25), demonstrating real pay-for-performance sensitivity.

Governance — clean. PHM is single-class (one share, one vote; no super-voting founder block — confirmed in the 2026 proxy), with an 11-member board on annual terms. There is a residual Series A Junior Participating Preferred Share Purchase Rights mechanism (a vestigial antitakeover provision, not a second voting class). CEO Ryan Marshall has led since September 2016 (~9.5 years) and CFO Jim Ossowski stepped up in February 2025. This is materially cleaner governance than Lennar’s dual-class structure (where the Miller family controls ~39% of the vote for ~8% of the economics).

Insider behavior — a mild negative. Across ~30 recent Form 4 filings (Feb-2025 → Jun-2026), there were zero open-market purchases (code P) — only routine grants (A), tax-withholding (F), planned sales (S), and gifts (G). At a stock near its all-time high this is unsurprising, but it means there is no insider conviction-buying signal to support a “the stock is cheap” view; if anything, the absence of buying at all-time highs is consistent with insiders not viewing the price as a bargain.

Verdict: Management has allocated capital intelligently across every dimension — a disciplined, returns-first land strategy; a large, consistent, accretive buyback; a sensible low dividend; opportunistic balance-sheet management; a genuinely well-designed, ROIC-and-margin-linked comp plan with no empire metric; and clean single-class governance. The only quibbles are the inherently pro-cyclical timing of the buyback and the absence of insider buying — both minor. This is a top-decile capital allocator in the coverage universe.

8. Changes and Headwinds — Last Two Years

The earnings cycle turned. The dominant change is the roll-over from the FY2024 peak: home-sale gross margin compressing 28.9% → 26.3% → 24.4% (Q1-26); EPS declining from the (reserve-flattered) $14.69 FY24 peak to $11.12 (FY25) and ~$1.79 in Q1-26 (−34% YoY); and FY25 closings (−5%), orders (−4%), and backlog (−19%) all falling. This is a normal cyclical inflection, not a crisis, but the direction of travel on margin and earnings is unambiguously down.

Leadership/board. A clean CFO transition (Bob O’Shaughnessy out, Jim Ossowski in, February 2025) and routine board refreshment (director not re-standing under the age policy). CEO Ryan Marshall continues. No disruptive turnover.

Capital-return acceleration. Two $1.5B buyback authorizations (Jan-2025, Apr-2026), an +18% dividend hike (Jan-2026), and a Feb-2026 debt refinancing into lower coupons — management leaning into shareholder returns and balance-sheet optimization as the cycle softens.

Strategic/operational shifts. A deliberate shift back toward 60% build-to-order / 40% spec (from ~40/60) to protect margin and reduce inventory risk; starts cut below orders to clear spec; increasing land optionality; and the exit of a manufacturing/component operation (the FY25 goodwill + PP&E impairments). All are margin/return-protective, returns-discipline moves.

Macro/policy headwinds and one tailwind. Headwinds: a ~6.4–6.5% 30-year mortgage and multi-decade-low affordability freezing the entry level; a “K-shaped” consumer; Texas-specific softness (revenue −22% in FY25); and the newer cost pressures of tariffs (+~$9–11k/home) and immigration/labor enforcement in the trades. The one tailwind: the June-2026 “21st Century ROAD to Housing Act” and renewed rate-cut hopes, which drove the late-June sector rally — sentiment-positive, but with limited near-term fundamental impact.

Verdict: The changes are mixed: thesis-confirming on quality and capital allocation, thesis-cautioning on the cycle. Management is executing well — defending margin, accelerating returns, optimizing the balance sheet — but it is doing so because the operating environment has deteriorated and earnings are compressing from a peak. The net effect on the investment case at the current price is cautionary: a great operator is being run well into a softening cycle, while the stock sits near all-time highs.

9. Risk Analysis (Risk Matrix)

Catastrophic-loss / total-loss risk: very low. Net debt-to-capital of ~0% (net cash), ~$2.6B liquidity, negligible goodwill, increasing land optionality, and conservative accounting make a solvency event implausible short of a 2008-scale depression — in which PHM would be a survivor and share-taker. The realistic downside is a valuation/return re-rate — from ~2.06x book toward the ~1.5x it traded at the 2022 lows, i.e. a ~25–30% drawdown toward book — driven by the earnings cycle, not enterprise impairment. This is a peak-multiple-on-peak-earnings risk, not a permanent-capital-loss risk.

10. Valuation Discussion (Embedded Expectations)

The right framework. Homebuilders are valued on price-to-book and through-cycle (normalized) earnings, not on trailing or peak P/E. PHM’s trailing P/E of ~13.3x looks modest, but that is the cyclical trap: it is a low multiple on near-peak, declining earnings. The cleaner reads are P/B and normalized EPS — and on those, PHM is expensive relative to its own history.

The own-history valuation tell (the crux). PHM’s own-history valuation percentiles place it at the richest end of its recorded range: composite 90th percentile, price-to-sales 97th, P/E 92nd, P/B 82nd. Price-to-sales — the metric least distorted by the earnings cycle — at the 97th percentile is the single highest-signal datum here: PHM has essentially never been more expensive on revenue. The P/B of ~2.06x sits at the top of its normal (ex-2021-bubble) range (it ran ~1.5x at the 2022 lows, ~2.4–2.6x in recent years, and a bubble ~3.5x in 2021). This is the valuation signature of a high-quality cyclical that the market has correctly re-rated for quality — and then pushed to the top of the cycle.

Cross-sectional comp set.

(P/B from market data; peer returns approximate, sector-sourced.)

The cross-sectional read: PHM trades at the second-highest P/B in the group (behind only NVR) and earns the highest margins/ROIC of the scale builders — it is expensive because it is the best, the mirror image of Lennar (cheapest because worst). The premium over DHI (~2.06x vs ~1.9x) is modest and arguably justified by PHM’s superior margin/mix; the premium over LEN (~2x vs ~1.07x) is large and entirely earned by the 15% vs 6.8% ROIC gap. The cross-sectional case is not that PHM is overpriced versus peers — it is fairly priced versus peers for its quality. The richness is versus its own history, on a declining earnings stream.

Normalized earnings power. On ~$67 book and the QoE-adjusted view that FY24’s $14.69 was reserve-inflated:

• Trough/current ROE ~18–24% → ~$10–12 EPS (roughly where FY25/TTM sit).
• Mid-cycle ROE ~18% → ~$12 normalized EPS (the QoE-cleaned mid-cycle figure).
• Peak ROE ~22–24% (FY24-type, ex-reserve) → ~$13–14 EPS.

At $137.61, against ~$12 mid-cycle EPS, the stock trades ~11.5x normalized earnings — not expensive if you believe mid-cycle is the right anchor and the cycle stops compressing. But earnings are still falling (Q1-26 annualizes to ~$7.2), so the near-term risk is that reported EPS undershoots mid-cycle before any recovery, and the market re-rates the multiple down on the way.

Reverse the price. A high-quality builder trades at ~2x book when the market believes through-cycle ROE comfortably exceeds cost of equity — which for PHM (15%+ ROIC, 18–24% ROE) it does. So ~2.06x is internally consistent with PHM’s quality. The embedded expectation at $137.61 is therefore not “PHM is mediocre” but “PHM’s superior returns and the rate-cut cycle will both hold/improve from here.” The market is paying a full, quality-justified multiple at the top of the stock’s own range, on earnings that are declining, with the upside leg (rate relief) already being celebrated. That is an asymmetric setup: limited multiple-expansion room (already 82nd–97th percentile), real multiple-compression room if the cycle disappoints.

Scenario zones (embedded-expectations, not price targets):

The crux: PHM is the best operator at a quality-justified-but-historically-rich multiple, on earnings rolling over from a (reserve-flattered) peak, with the bull leg dependent on a rate cut the market has started to price. No price target, no recommendation — the embedded expectation is that quality returns and the rate-cycle both cooperate; the asymmetry is that this is mostly priced in.

11. Variant Perception

Consensus. PHM is widely regarded — correctly — as the best-run, highest-return scale homebuilder: premium move-up/Del Webb mix, group-leading margins and ROIC, fortress balance sheet, exemplary capital allocation, near all-time highs because it has earned it. The bull narrative: “own the highest-quality builder, with a demographic tailwind (Del Webb), through a shallow cycle, and collect the rate-cut option for free.” The factor tape agrees it is a quality-and-momentum name (near ATH, +33% over a year, loading on Quality and Momentum as well as Value).

Strongest bull case. (1) Best operator, best mix — the Del Webb/move-up tilt is the right place to be in a K-shaped market and the right long-duration demographic bet. (2) Above-WACC ROIC through the cycle (15%+ even at the FY25 trough) — genuine value creation, unlike LEN. (3) Fortress balance sheet + best-in-class capital allocation — net cash, ~26% share shrinkage, ROIC-linked pay, clean governance. (4) Rate-relief triple-lever — the −0.84 InterestRate loading means every 50–100 bps off the mortgage disproportionately reignites the entry-level leg, cuts incentive spend, and re-expands margin. (5) Earnings less deteriorated than they look — the FY24 “peak” was reserve-inflated, so the real decline is shallower and current earnings are nearer a sustainable ~$12.

Strongest bear case. (1) Richest-ever own-history valuation (composite 90th, P/S 97th) on a declining earnings stream — the cyclical peak-multiple-on-peak-earnings trap. (2) Earnings still rolling over — GM 28.9% → 24.4%, EPS −34% YoY in Q1-26, orders/backlog down; the bottom is not visibly in. (3) The whole thesis is a rate bet already being celebrated — the late-June +9% pop was the market pre-paying for rate cuts and a housing bill with limited near-term impact. (4) ~25–30% downside to book if the cycle disappoints, versus modest upside (multiple already at the top of its range). (5) No margin of safety and no insider buying — unlike LEN (near book, contrarian), PHM offers quality at a full price with insiders not buying.

The 3–5 assumptions that matter most, with falsification tests:

1. Is the earnings cycle near a bottom or still rolling over? Falsifies bear: GM stabilizes >25% and orders re-accelerate within 2–3 quarters. Falsifies bull: GM breaks below ~23% with orders still declining.
2. Does the rate path cooperate? Falsifies bull: 30-yr mortgage stays 6.5%+ through 2026–27. Falsifies bear: it falls toward ~5.5% and absorption + margin inflect up.
3. Is ~2.06x book “fair-for-quality” or a cyclical peak multiple? Hinges on #1–#2; at the 82nd–97th percentile of its own history, the burden of proof is on continued cooperation.
4. Is mid-cycle EPS ~$12 (QoE-cleaned) the right anchor, and is the market over- or under-paying for it? At ~11.5x mid-cycle, fair if the cycle holds; expensive if EPS undershoots toward ~$8–10 first.
5. Does the Del Webb demographic tailwind justify a structurally higher multiple? The best long-term bull argument; real but slow, and already partly in the multiple.

The factor-positioning read (where consensus may be offsides). FactorsToday: a dominant Home-Construction industry beta of 2.00 (Market ~1.0, R² 0.87 — overwhelmingly factor/rate-driven, with low idiosyncratic vol of just ~12.6%), an explicit InterestRate loading of −0.84 (the rate/affordability bet), and a notable simultaneous loading on Value (+0.25 to +0.62), Quality (+0.29 to +0.40), and Momentum (+0.20 to +0.26) plus a SmallSize tilt (~0.8–1.1). Risk-adjusted track record (annualized): y1 +32.8% (Sharpe 0.88), m6 +34%, m3 +109% (the recent surge), with a lifetime maxDD of −89.7% (the GFC) but only −38% over five years. The related-stock cluster is the builder cohort plus the homebuilder ETFs (ITB 0.99, NAIL 0.99, LEN/LEN-B ~0.98, MTH 0.98, DHI 0.98, KBH 0.98, TOL 0.98) — confirming PHM’s identity is the rate-levered homebuilder trade.

The interpretation: this is a quality cyclical in an uptrend near its highs — momentum, not a falling knife, and the polar opposite of Lennar’s basing-near-book setup. The crowd reads “best operator + Del Webb + fortress + rate-cut option” and pays up; the variant risk is that the entire complex is a high-R², rate-driven trade that has already rallied ~33% in a year and ~9% in three days on a rate-cut/housing-bill bid — and the stock is being asked to deliver into a declining earnings cycle at the richest multiple in its own history. The price will turn on the rate path, not on idiosyncratic execution (idio vol is tiny); if the rate-cut narrative that drove the June bounce stalls while margins keep compressing, the best operator in the group still de-rates toward book — because what you are really buying at $137.61 is a leveraged, fully-priced bet on the housing-rate cycle wearing a quality label.

12. Fact vs. Interpretation Table

13. Open Questions

1. Where is the earnings bottom? Q1-26 EPS annualizes to ~$7.2 versus a normalized ~$12 — is FY26 a shallow dip or the start of a deeper compression? Watch quarterly home-sale GM and order trends.
2. How much of the FY25 margin compression is reversible (buydowns) versus structural (land-cost inflation, tariffs)? Buydowns reverse with rates; land/tariff costs may not.
3. Quantify the QoE-normalized earnings power precisely. Strip the FY24 reserve release and FY25 impairments across multiple years to pin the true mid-cycle EPS — is it ~$11, ~$12, or ~$13?
4. Texas trajectory. Revenue −22% in FY25 — is this a one-cycle oversupply correction or a structural share/affordability problem in a key market?
5. Does the Del Webb tailwind warrant a structurally higher multiple, or is the active-adult advantage already fully reflected in the ~2x book?
6. Buyback discipline at the highs. Will management keep repurchasing at ~2.06x book near ATH, or hold dry powder for a cyclical drawdown? The latter would be the contrarian-master move.

14. What Must Be True

For the bull case (best operator, shallow cycle, rate relief, multiple holds and book compounds toward ~$145–175):

• The earnings cycle must bottom soon: home-sale gross margin must stabilize above ~25% and orders must re-accelerate within a few quarters, confirming FY26 is a shallow dip, not a peak.
• The 30-year mortgage must ease toward ~5.5%, reigniting the entry-level/Centex leg, cutting incentive spend, and re-expanding margin.
• The ~2.06x book multiple (already 82nd–97th percentile of its own history) must at least hold while book compounds via retained earnings and ~26%-and-counting share shrinkage.
• Falsification test: if, over the next 2–3 quarters, home-sale gross margin breaks below ~23% with orders still declining and the rate-cut narrative stalling, the bull case is broken — the stock is a peak multiple on peak earnings and de-rates toward book.

For the bear case (peak multiple on peak earnings; de-rate toward book ~$100–115):

• The earnings cycle must keep rolling over: GM toward the low-20s, EPS undershooting toward ~$8–10, orders/backlog continuing to shrink.
• Rates must stay 6.5%+ through 2026–27, keeping the entry-level frozen and incentives elevated.
• The richest-ever multiple must mean-revert toward the ~1.5–1.7x book PHM traded at the 2022 lows as the market stops paying a peak multiple for a declining cyclical.
• Falsification test: if the mortgage rate falls toward ~5.5% and PHM’s gross margin and order growth both inflect higher (GM stabilizing >25%, orders positive) within a few quarters, the de-rate thesis is broken — the cycle was shallow, the best operator keeps compounding, and ~2x book proves fair-to-cheap for the quality.

15. Source Appendix

See the Source Appendix (Appendix B below) for the full citation list. Primary sources: PulteGroup FY2025 Form 10-K (filed 2026-02-04); FY2021–24 Form 10-Ks; Q1-FY2026 Form 10-Q and earnings 8-Ks; DEF 14A proxy (2026); Q1-2026 / Q4-2025 earnings-call transcripts; multi-year financial statements, ratios, per-share data, and enterprise value; price history and valuation-percentile data; a financial news service (housing-bill catalyst); a quantitative factor model; and the Greenwald/Marathon analytical frameworks.

APPENDIX A — Standard Diligence Questionnaire

Supplemental to the research memo. Report date 2026-06-27. Fact / Interpretation / Assumption labeled where it matters.

General

What thoughtful questions have other investors asked about this company? The central one: is the current valuation (richest in PHM’s own history) justified by its best-in-class quality, or is it a peak multiple on peak-cycle earnings? Secondary lines: (1) where is the earnings bottom, given GM compressed 28.9% → 24.4% and EPS fell 34% YoY in Q1-26? (2) How much of the margin compression is reversible buydowns versus structural land-cost/tariff inflation? (3) Is the Del Webb active-adult demographic tailwind a durable, multiple-justifying advantage? (4) Why keep buying back stock at ~2.06x book near all-time highs rather than holding dry powder for a cyclical drawdown? (5) Is the move-up/active-adult mix a true competitive moat or just favorable cyclical positioning? (6) How exposed is PHM to Texas/Sun Belt oversupply (Texas revenue −22% in FY25)?

Cyclicality & Earnings Nature

Are earnings at a cyclical high or low? High and beginning to descend. Diluted EPS peaked at $14.69 (FY24, itself flattered by a ~$334M insurance-reserve release), fell to $11.12 (FY25), and to ~$1.79 in Q1-26 (−34% YoY); TTM ~$10.34. Home-sale gross margin compressed 28.9% → 26.3% → 24.4%. This is a cyclical rolling over from a peak — not a trough. ROE ~24% and ROIC ~15.2% remain high (above WACC) even in the down year. (FACT.)

Driven by the external environment or internal actions? Predominantly external, with disciplined internal response. External: ~6.4–6.5% mortgages, frozen resale market, multi-decade-low affordability, “K-shaped” consumer, Texas oversupply, emerging tariff/labor-cost pressure. Internal: PHM is defending margin/returns (cutting starts below orders, shifting back to 60% build-to-order, increasing land optionality) rather than buying volume with price as Lennar does. (FACT on figures / INTERPRETATION on causal split.)

How stable are revenues? Cyclical and non-recurring. ~98% of revenue is the one-off home sale; backlog (8,495 units / $5.27B, −19% YoY) gives only a few months’ visibility; there is no recurring/annuity revenue beyond the captive-mortgage attach, which itself rides home-sale volume. (FACT.)

Outlook for products/services? Demand is bifurcated: resilient move-up/active-adult (PHM’s strength), frozen first-time. Long-run demand is supported by a multi-million-unit housing deficit and aging-demographic active-adult tailwind, but near-term activity is gated by the mortgage rate. (INTERPRETATION.)

How big is this market — growing, shrinking, domestic or international? Domestic only (US). New single-family construction is structurally undersupplied versus the long-run demographic need but cyclically depressed by affordability; single-family starts fell ~7% in 2025. A large, mature, consolidating market — top-10 builders ~45% of closings. (FACT/INTERPRETATION.)

Business Quality & Competitive Moat

Is the industry getting more or less competitive? Slowly less, via consolidation (public builders take share from the private long tail), but the product remains commoditized with no demand captivity. (INTERPRETATION.)

How profitable is the business (ROIC, ROE)? The most profitable scale builder. FY25 ROIC ~15.2% (above WACC), ROE ~24%; both led the cohort. Through-cycle ROIC has stayed ~15–24% — never below cost of capital, unlike Lennar (6.8%). (FACT.)

How profitable is the industry — competitors, barriers to entry? Industry through-cycle ROIC ~10–12% (≈ WACC) — structurally average. Barriers: capital, land access/entitlement know-how, scale purchasing, brand in niches (Del Webb). Low for small private builders; meaningful for national scale. (INTERPRETATION.)

Can the business be easily understood? Yes — build and sell homes; capture mortgage; manage land and capital. The only subtleties are land-strategy economics (owned vs optioned) and the insurance-reserve accounting. (FACT.)

Can it be undermined by foreign low-cost labor? No — homebuilding is inherently local (land, entitlement, on-site construction). The labor input is exposed to immigration-enforcement disruption, raising cost, but the business cannot be offshored. (FACT/INTERPRETATION.)

Do brands matter? Partially — and this is PHM’s edge. In the commodity core, no. But Del Webb carries genuine weight with 55+ active-adult buyers, and Pulte/DiVosta with move-up buyers — a rare instance of homebuyer brand preference that supports PHM’s premium ASP (~$566k) and margin. (INTERPRETATION.)

Nature of competition? Price, location, product, incentives (mortgage-rate buydowns), and speed of move-in. PHM competes less on price in its move-up/active-adult niches and more on community/amenity/brand. (INTERPRETATION.)

Customers’ switching costs? Zero in the commodity sense — a homebuyer is a one-time customer with no lock-in. (FACT.)

Financial Condition & Balance Sheet

Assets not fully recognized on the balance sheet? The ~133,528 optioned lots (controlled, not owned) are off-balance-sheet land control — a positive optionality (and a ~$1.3B max walk-away exposure via deposits/pre-acquisition costs). The Del Webb brand value is not capitalized. (FACT/INTERPRETATION.)

Off-balance-sheet liabilities? Land-option purchase obligations (~$10.0B remaining purchase price, mostly non-binding/walk-away) and construction-defect/warranty exposure (managed via self-insurance reserves). No unusual hidden leverage. (FACT.)

How conservative is the accounting? Generally conservative, with one volatile line: the self-insurance/construction-defect IBNR reserve, whose releases swung $334M (FY24) → $42M (FY25) → $131M (FY23) through SG&A, materially distorting year-to-year optics. Land/option discipline (regular impairments and write-offs taken) is conservative. Normalize the reserve swings before comparing years. (FACT/INTERPRETATION.)

How CapEx-hungry is the business? Low fixed-capex (homebuilder PP&E is minimal); the capital intensity is working capital — land and homes under construction (~$12.9B inventory). PHM is moderately land-light (43% owned), less capital-intensive than land-heavy peers but more than Lennar (98% optioned) or NVR. (FACT.)

Capital Allocation & Management

How much FCF does the business generate, and how is it used? FY25 OCF ~$1.87B (~$9.45/share, ~84% of net income), with negligible capex → FCF ~$1.87B. Used for buyback (~$1.2B), dividend (~$0.18B), and land reinvestment; the balance is held as net cash. FCF fluctuates with land investment year to year but roughly tracks net income through the cycle. (FACT.)

Significant acquisitions recently? No — PHM is not an aggressive acquirer; growth is organic plus small land/operational deals. It exited a manufacturing/component operation in FY25 (taking goodwill/PP&E impairments). A capital-discipline positive. (FACT.)

Buying back shares? Yes, aggressively and accretively — share count down ~26% over five years (268.5M → 192.7M); two $1.5B authorizations (Jan-25, Apr-26). Critique: pro-cyclical (buying at ~2.06x book near ATH vs ~1.5x at the 2022 lows). (FACT/INTERPRETATION.)

Issuing large amounts of new shares to insiders? No — SBC is modest (~$55M/year, ~0.3% of revenue), well below the buyback. (FACT.)

Compensation policy of directors/management? Among the best-designed in the sector — annual bonus on adjusted pre-tax income + operating margin; LTI PSUs on relative TSR + ROIC + operating margin; relative ROE also used; ~94% of CEO pay variable; no volume/revenue empire metric. CEO total comp fell with results ($18.4M → $15.4M FY24→FY25). (FACT.)

Motivations of management? Returns-and-margin-focused, demonstrated by starts discipline, the build-to-order shift, and the ROIC-linked pay plan. Single-class governance (no entrenched founder block) supports accountability. The absence of insider open-market buying is a mild caution. (INTERPRETATION.)

Valuation & Market Data

Is the stock an ADR, MLP, or K-1 issuer? No — PHM is a US C-corporation (NYSE common stock), issuing a 1099, not a K-1. Single share class. (FACT.)

Dividend policy? Low and growing: $0.92/share FY25, raised +18% to $1.04 annualized (Jan-2026); ~0.73% yield, ~8% payout. Deliberately secondary to buyback. (FACT.)

How profitable is the business? The most profitable scale builder — see above (ROIC ~15%, ROE ~24%, home-sale GM 26.3%, all group-leading). (FACT.)

Is net income diverging from cash from operations? Modestly and cyclically — FY25 OCF ~$1.87B was ~84% of net income, with the gap being land/working-capital investment; in heavy land-buying years (FY22) OCF fell well below NI. No accrual-quality red flag; the swings are land-investment timing. (FACT.)

Risks & Downside

What factors would cause the stock to decline? (1) Continued earnings roll-over (GM toward low-20s, EPS toward $8–10); (2) mortgage rates staying 6.5%+ or rising; (3) de-rating from the richest-ever multiple (~2.06x book) toward book (~$100–115); (4) Texas/Sun Belt oversupply deepening; (5) tariff/labor cost inflation compressing margin further; (6) a stalling of the rate-cut narrative that drove the June bounce. (INTERPRETATION.)

Risk of a catastrophic loss? Very low. Net-cash balance sheet, ~$2.6B liquidity, negligible goodwill, increasing land optionality — solvency is implausible short of a 2008-scale depression (in which PHM would be a survivor). (FACT/INTERPRETATION.)

Chance of a total loss? Negligible. The realistic downside is a valuation/return drawdown toward book (~25–30%), not enterprise impairment. (INTERPRETATION.)

Recent News & Events

Has the business environment changed recently? Yes — the cycle is softening (FY25 first down year; Q1-26 EPS −34% YoY), but late-June 2026 brought a sentiment tailwind: the bipartisan “21st Century ROAD to Housing Act” passed Congress and a KB Home Q2 beat drove “homebuilders’ best day in a year” (sector +9% over three days). Treat as sentiment/momentum, not a fundamental re-rating. (FACT on events / INTERPRETATION on impact.)

Significant acquisitions? None recently; PHM exited a manufacturing/component operation in FY25. (FACT.)

Change in accounting policies? None material; the insurance-reserve releases are estimate revisions, not policy changes. (FACT.)

Recent changes — new markets, facilities, management? CFO transition (Ossowski in, Feb-2025); +18% dividend hike and two $1.5B buyback authorizations; Feb-2026 debt refinancing into lower coupons; community-count growth (+9% in Q1-26); strategic shift back toward 60% build-to-order. CEO Ryan Marshall continues (since 2016). (FACT.)

APPENDIX B — Source Appendix

Report date 2026-06-27. Primary sources first. Figures cited in the memo trace to these.

Primary — SEC Filings (US filer, CIK 0000822416; mirrored locally to output/PHM/sources/)

• PulteGroup FY2025 Form 10-K (filed 2026-02-04; phm-20251231.htm). Source of: consolidated and segment revenue/pretax income; closings 29,572 / ASP ~$566k; new orders 27,914 / $15.5B; backlog 8,495 / $5.27B; home-sale gross margin 26.3% (vs 28.9% FY24); SG&A 9.4%; buyer mix 38% first-time / 40% move-up / 22% active-adult; land position 234,632 lots (43% owned / 57% optioned), ~$10.0B remaining option purchase price, $724.2M option deposits; FY25 land impairments $77.4M, option write-offs $48.4M, goodwill impairment $28.6M, PP&E impairment $49.6M; insurance-reserve adjustments ($42.3M FY25, $333.9M FY24, $130.8M FY23); debt, cash, equity.
• Form 10-K, FY2021–FY2024 (phm-2021…–phm-2024…). Multi-year revenue, margin, EPS, ROE/ROIC, share count, land history.
• Form 10-Q, Q1 2026 (filed 2026-04-23; phm-20260331.htm). Q1-26: home-sale revenue $3.3B, GM 24.4%, EPS $1.79 (−34% YoY); net income $347.0M; orders 8,034 (+3%); community count 1,043 (+9%); cancellation 13%; buyback $308.2M; cash $1.8B; net debt/cap ~zero.
• DEF 14A proxy (filed 2026-03-13). Executive compensation metrics (annual: adjusted pre-tax income + operating margin; LTI PSUs: relative TSR + ROIC + operating margin; relative ROE; FY25 LTI payout near max); CEO Ryan Marshall (since Sept 2016), total comp $15.39M FY25; CFO Ossowski $3.87M; single-class share structure; 11-member board; Series A Junior Participating Preferred rights.
• Form 8-K (2024–2026). Quarterly earnings releases; $1.5B buyback authorizations (Jan-2025, Apr-2026); +18% dividend increase (to $0.26/qtr, Jan-2026); $800M senior-note issuance (Feb-2026, 4.25% due 2031 / 4.90% due 2036) and revolver upsize/extension to $1.75B/2031; CFO transition (O’Shaughnessy → Ossowski, Feb-2025).
• Form 4 corpus (CIK 822416, EDGAR). ~30 filings Feb-2025 → Jun-2026; zero open-market purchases (code P); routine grants/withholding/sales.

Primary — Management Commentary (transcripts)

• PulteGroup Q1 2026 earnings call (2026-04-23; via ROIC.ai). Source of: incentives 10.9% of gross sales price; option/lot-premium spend >$100,000/home; build-to-order 43% of orders (shift back toward 60/40 BTO/spec); starts ~6,500 vs orders ~8,000; Florida orders +18%; ~230,000 lots controlled incl. ~35,000 owned-and-finished; ~60% Pulte/Del Webb (affluent) mix; “K-shaped” demand framing; net debt-to-capital “effectively zero”; $1.3B land investment, $360M returned to shareholders in the quarter.
• PulteGroup Q4 2025 earnings call (2026-01-29; via ROIC.ai). FY25 results and FY26 framing.

Quantitative Data Sources (third-party; reconciled to filings)

• Aggregated financial statement data. Multi-year income statement, balance sheet, cash flow; profitability ratios (ROE, ROA, ROIC, margins); per-share data; enterprise value; valuation multiples (own-history). Used for the FY20–25 financial trend tables and EV. (Book value per share ~$66–67 taken from the filing.)
• Price history (split/dividend-adjusted). Five-year split/dividend-adjusted OHLC; price arc (5yr low $34.99 17-Jun-2022; ATH $146.95 18-Oct-2024; 52-wk $104.63–141.96; close $137.61 26-Jun-2026; −6.4% off ATH); EMAs, beta.
• Own-history valuation percentiles. Own-history percentiles: composite 90.4th, P/E 91.8th (13.31x), P/B 82.1th (2.06x), P/S 97.2th (1.61x); TTM EPS $10.34; BVPS $66.82; sales/share $85.31 (as of 2026-06-26).
• Financial news service. Catalyst items: 24-Jun-2026 “21st Century ROAD to Housing Act” passage + KB Home Q2 beat → “homebuilders’ best day in a year”; 01-Jun-2026 Berkshire homebuilder bet.
• Quantitative factor model. Loadings: Industry Home Construction 2.00, Market ~1.0, InterestRate −0.84, Value +0.25/+0.62, Quality +0.29/+0.40, Momentum +0.20/+0.26, SmallSize ~0.8–1.1; R² 0.87; idiosyncratic vol ~12.6%. Leaderboard (annualized): y1 +32.8% (Sharpe 0.88), m6 +34%, m3 +109%; lifetime maxDD −89.7%, y5 maxDD −38%. Related: ITB, NAIL, LEN/LEN-B, MTH, DHI, KBH, TOL, GRBK.

Peer / Sector Context (public)

• Public homebuilder peers used for cross-read and comp framing: D.R. Horton (DHI), Lennar (LEN), NVR, Toll Brothers (TOL), Meritage (MTH), KB Home (KBH), M/I Homes (MHO) — their public filings and disclosures inform the cross-sectional comp set (P/B, ROE/ROIC, gross margin, ASP).

Analytical Frameworks

• Greenwald & Kahn, Competition Demystified (barriers to entry / moat-type taxonomy; ROIC and market-share-stability tests).
• Marathon / Chancellor, Capital Returns (supply-side capital-cycle analysis; the homebuilding capital cycle).

All third-party aggregated data is non-primary and reconciled to SEC filings; where a figure drives a verdict, it is reproducible from the underlying statement line items. No analyst/aggregator price target is adopted. The author holds no position in the company; no position is asserted or implied. This is general information, not investment advice.